Grove AI Secures $4.9M: A New Frontier in Clinical Trial Enrollment Efficiency
Grove AI, an emerging startup, has successfully raised $4.9 million to revolutionize clinical trial enrollment. The company aims to tackle inefficiencies and elevate diversity in trials using its AI-powered platform, featuring the savvy AI agent named Grace. With this funding, led by A* alongside other major investors, Grove AI is set to expand partnerships and enhance its innovative platform, fostering more inclusive and streamlined clinical trials.
Jan 9